2009 Fiscal Year Final Research Report
Spinal ceramide is responsible for the development of neuropathic pain.
Project/Area Number |
20890200
|
Research Category |
Grant-in-Aid for Young Scientists (Start-up)
|
Allocation Type | Single-year Grants |
Research Field |
Anesthesiology/Resuscitation studies
|
Research Institution | Wakayama Medical University |
Principal Investigator |
KOBAYASHI Yuka Wakayama Medical University, 医学部, 助教 (20511562)
|
Project Period (FY) |
2008 – 2009
|
Keywords | 神経障害性疼痛 / スフィンゴ脂質 / グリア細胞 / サイトカイン / アロディニア |
Research Abstract |
In this study, the involvement of spinal ceramide in neuropathic pain through microglia activation and inflammatory cytokines increase was revealed. Therefore, ceramide was nominated as a novel therapeutic target of neuropathic pain.
|